Zhao, K., Wang, C., Shi, F., Huang, Y., Ma, L., Li, M., & Song, Y. (2021). Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy. BMC Cancer.

Zhao, Kewei, Chunsheng Wang, Fang Shi, Yong Huang, Li Ma, Minghuan Li, a Yipeng Song. "Combined Prognostic Value of the SUVmax Derived From FDG-PET and the Lymphocyte-monocyte Ratio in Patients With Stage IIIB-IV Non-small Cell Lung Cancer Receiving Chemotherapy." BMC Cancer 2021.

Zhao, Kewei, et al. "Combined Prognostic Value of the SUVmax Derived From FDG-PET and the Lymphocyte-monocyte Ratio in Patients With Stage IIIB-IV Non-small Cell Lung Cancer Receiving Chemotherapy." BMC Cancer 2021.